These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22505556)

  • 1. microRNA and the pathogenesis of ovarian cancer--a new horizon for molecular diagnostics and treatment?
    Kuhlmann JD; Rasch J; Wimberger P; Kasimir-Bauer S
    Clin Chem Lab Med; 2012 Jan; 50(4):601-15. PubMed ID: 22505556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical relevance of circulating cell-free microRNAs in ovarian cancer.
    Nakamura K; Sawada K; Yoshimura A; Kinose Y; Nakatsuka E; Kimura T
    Mol Cancer; 2016 Jun; 15(1):48. PubMed ID: 27343009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA and gynecologic cancers.
    Kanekura K; Nishi H; Isaka K; Kuroda M
    J Obstet Gynaecol Res; 2016 Jun; 42(6):612-7. PubMed ID: 27098274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of Dicer expression in ovarian cancer-link to global microRNA changes and oestrogen receptor expression.
    Faggad A; Budczies J; Tchernitsa O; Darb-Esfahani S; Sehouli J; Müller BM; Wirtz R; Chekerov R; Weichert W; Sinn B; Mucha C; Elwali NE; Schäfer R; Dietel M; Denkert C
    J Pathol; 2010 Feb; 220(3):382-91. PubMed ID: 19960504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
    Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
    Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities.
    Chen SN; Chang R; Lin LT; Chern CU; Tsai HW; Wen ZH; Li YH; Li CJ; Tsui KH
    Int J Environ Res Public Health; 2019 Apr; 16(9):. PubMed ID: 31035447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of microRNA expression in serous ovarian carcinoma.
    Li Y; Yao L; Liu F; Hong J; Chen L; Zhang B; Zhang W
    Int J Mol Med; 2014 Aug; 34(2):491-8. PubMed ID: 24939816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of common oncogenic and early developmental pathways in the ovarian carcinomas controlling by distinct prognostically significant microRNA subsets.
    Kuznetsov VA; Tang Z; Ivshina AV
    BMC Genomics; 2017 Oct; 18(Suppl 6):692. PubMed ID: 28984201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The modularity and dynamicity of miRNA-mRNA interactions in high-grade serous ovarian carcinomas and the prognostic implication.
    Zhang W; Edwards A; Fan W; Flemington EK; Zhang K
    Comput Biol Chem; 2016 Aug; 63():3-14. PubMed ID: 26949157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of microRNAs in cancers of the female reproductive tract: insights from recent clinical and experimental discovery studies.
    Logan M; Hawkins SM
    Clin Sci (Lond); 2015 Feb; 128(3):153-80. PubMed ID: 25294164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epithelial-mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: prognostic value and prospective role in ovarian cancer therapeutics.
    Koutsaki M; Spandidos DA; Zaravinos A
    Cancer Lett; 2014 Sep; 351(2):173-81. PubMed ID: 24952258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. microRNA and Ovarian Cancer.
    Langhe R
    Adv Exp Med Biol; 2015; 889():119-51. PubMed ID: 26659000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNAs and ovarian cancer: An overview.
    Deb B; Uddin A; Chakraborty S
    J Cell Physiol; 2018 May; 233(5):3846-3854. PubMed ID: 28703277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs in Ovarian Cancer.
    Katz B; Tropé CG; Reich R; Davidson B
    Hum Pathol; 2015 Sep; 46(9):1245-56. PubMed ID: 26216350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating microRNA expression profiles in ovarian cancer.
    Ayaz L; Çayan F; Balci Ş; Görür A; Akbayir S; Yıldırım Yaroğlu H; Doğruer Unal N; Tamer L
    J Obstet Gynaecol; 2014 Oct; 34(7):620-4. PubMed ID: 24911418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of microRNAs in ovarian cancer pathogenesis and potential clinical implications.
    Mezzanzanica D; Bagnoli M; De Cecco L; Valeri B; Canevari S
    Int J Biochem Cell Biol; 2010 Aug; 42(8):1262-72. PubMed ID: 20035894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel serum microRNA panel to discriminate benign from malignant ovarian disease.
    Langhe R; Norris L; Saadeh FA; Blackshields G; Varley R; Harrison A; Gleeson N; Spillane C; Martin C; O'Donnell DM; D'Arcy T; O'Leary J; O'Toole S
    Cancer Lett; 2015 Jan; 356(2 Pt B):628-36. PubMed ID: 25451316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miRNA control of apoptotic programs: focus on ovarian cancer.
    Mezzanzanica D; Canevari S; Cecco LD; Bagnoli M
    Expert Rev Mol Diagn; 2011 Apr; 11(3):277-86. PubMed ID: 21463237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of microRNAs in ovarian cancer initiation and progression.
    Li SD; Zhang JR; Wang YQ; Wan XP
    J Cell Mol Med; 2010 Sep; 14(9):2240-9. PubMed ID: 20345848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes virus microRNA expression and significance in serous ovarian cancer.
    Pandya D; Mariani M; McHugh M; Andreoli M; Sieber S; He S; Dowell-Martino C; Fiedler P; Scambia G; Ferlini C
    PLoS One; 2014; 9(12):e114750. PubMed ID: 25485872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.